Gujarat Kidney & Super Speciality IPO

IPO Details
Bidding Date Dec 22, 2025	IPO Price Range ₹108 to ₹114 per share	IPO Size ₹250.80 Cr
Listing Exchange BSE, NSE	Listing Date Dec 30, 2025	Lot Size 128 Shares

Minimum Investment
₹14,592/128shares

IPO Timeline

Open DateDec 22, 2025

Close DateDec 24, 2025

Allotment FinalisationDec 26, 2025

Demat TransferDec 29, 2025

Refund InitiationDec 29, 2025

ListingDec 30, 2025

About Gujarat Kidney & Super Speciality IPO

Gujarat Kidney & Super Speciality is a regional healthcare provider in central Gujarat, operating a chain of mid-sized multispeciality hospitals focused on secondary and tertiary care. As of March 20, 2025, the company operates six multispeciality hospitals and three in-hospital pharmacies, including Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre with Ashwini Medical Store (Anand), with a total bed capacity of 400, an approved capacity of 355, and an operational capacity of 250 beds, providing comprehensive healthcare services to its patients. The Company is led by its Promoter and Managing Director, Dr. Pragnesh Yashwantsingh Bharpoda, who has over a decade of experience in the medical industry and has driven the Company’s geographical expansion through strategic acquisitions of multispeciality hospitals.

Gujarat Kidney & Super Speciality IPO Subscription Status

Date	QIB	NII	Retail	Total
TBA	0	0	0	0
TBA	0	0	0	0

Gujarat Kidney & Super Speciality IPO Financial Status

Particulars (in Rs. Crores)	30 Jun 2025	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	61.59	55.34	20.53	3.87
Total Income	15.27	40.40	5.48	0.00
Profit After Tax	5.40	9.50	1.71	-0.01
EBITDA	8.63	16.55	1.95	-0.01
Net Worth	30.56	25.71	10.80	0.37
Reserves and Surplus	19.42	14.57	10.60	0.17
Total Borrowing	4.03	3.88	1.94	—

Gujarat Kidney & Super Speciality IPO SWOT Analysis

Strengths

Pre-eminence in renal sciences, with established sub-superspecialties in urology and strong capabilities in other specialties.
Ability to attract, train and retain quality medical professionals.
Investment in infrastructure, processes and clinical excellence driving affordability, and a strong value proposition for stakeholders.
Professional management and experienced leadership.

Risks

Failure to complete the acquisition of Parekhs Hospital Private Limited on agreed terms may adversely affect the Company’s prospects.
Delays in issue proceeds may hinder payment for the Ashwini Medical Centre acquisition.
The Company’s hospitals operate on leased premises, and lease issues could materially impact its operations and financials.
The Company’s insurance may be insufficient to cover hospital claims, impacting its financials and reputation.